Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 384.00
High: 384.00
Low: 362.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Refinancing

5 Nov 2018 16:15

RNS Number : 3968G
Dalata Hotel Group PLC
05 November 2018
 

 

 

Dalata Hotel Group Announces New Debt Facilities 

ISE: DHG LSE: DAL

 

Dublin, 5 November 2018 | Dalata Hotel Group plc ("Dalata" or "the Company") is pleased to announce that it has successfully agreed a new €525 million debt facility, completing the refinance of its existing debt facilities. The new facilities, made up of a term loan facility of £176.5 million and a multi-currency revolving credit facility of €325 million, have a five year term expiring in November 2023 and replace the existing term loan (approximately €300 million) and revolving credit facilities of €190 million which were due to mature in February 2020.

The existing facilities were provided at different intervals since February 2015 by a banking group comprising of AIB Bank, Bank of Ireland, Barclays Bank and Ulster Bank. This group has been joined by HSBC Bank and Banco de Sabadell in providing these new facilities. Deloitte acted as Debt Advisor for the Company.

Dermot Crowley, Deputy CEO - Business Development & Finance, said:

"We are delighted to have secured new facilities out to October 2023. Our banking group have been very supportive of our growth ambitions since we first drew down facilities in February 2015. I am very pleased that HSBC and Banco de Sabadell have now joined our group and it demonstrates the growing attraction of Dalata to international lending institutions. The terms of the new facilities reflect the increased strength of the balance sheet since 2015. These new facilities will help support the continued growth of our business, reduce our financing costs as well as extending the maturity of our debt".

ENDS

About Dalata

Dalata Hotel Group plc is Ireland's largest hotel operator with a growing presence in the United Kingdom. The Group's current portfolio consists of 39 hotels with over 8,200 rooms. Dalata successfully operates Ireland's two largest hotel brands, Clayton Hotels and Maldron Hotels across Ireland and the UK, as well as managing a small portfolio of partner properties. 28 of the hotels are owned by Dalata, nine hotels are operated under lease agreements and two are operated under management agreements. For the half year 2018, Dalata reported revenue of €180.6 million and a profit after tax of €30.5 million. Dalata is listed on the Main Market of the Euronext Dublin (DHG) and the London Stock Exchange (DAL).

For further information visit: www.dalatahotelgroup.com

 

Contacts

 

Dalata Hotel Group plc

Tel +353 1 206 9400

Pat McCann, CEO

investorrelations@dalatahotelgroup.com

Dermot Crowley, Deputy CEO,

Business Development & Finance

Sean McKeon, Company Secretary and

Head of Risk and Compliance

Joint Company Brokers

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

Investor Relations and PR | FTI Consulting

Tel +353 1 66 33 686

Melanie Farrell

dalata@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODFSUFMIFASESF
Date   Source Headline
23rd Oct 201910:27 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSDirectorate Change
4th Oct 20199:47 amRNSHolding(s) in Company
3rd Oct 20194:25 pmRNSHolding(s) in Company
3rd Oct 20194:03 pmRNSHolding(s) in Company
3rd Oct 20192:30 pmRNSDirector/PDMR Shareholding
1st Oct 20191:33 pmRNSTotal Voting Rights
4th Sep 20192:59 pmRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirector/PDMR Shareholding
3rd Sep 20191:05 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSHalf-year Report
2nd Sep 20192:23 pmRNSTotal Voting Rights
29th Aug 20193:45 pmRNSHolding(s) in Company
23rd Aug 20198:55 amRNSDirector Declaration
1st Aug 20199:16 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSNotice of Results
11th Jul 20195:35 pmRNSHolding(s) in Company
10th Jul 201910:33 amRNSHolding(s) in Company
4th Jul 201910:57 amRNSBlock listing Interim Review
4th Jul 20199:44 amRNSHolding(s) in Company
1st Jul 20199:11 amRNSTotal Voting Rights
21st Jun 20197:00 amRNSEuronext Dublin Market Notice
20th Jun 20199:00 amRNSBlock listing application
4th Jun 20199:08 amRNSTotal Voting Rights
31st May 201910:05 amRNSHolding(s) in Company
2nd May 20194:54 pmRNSResult of AGM
2nd May 20197:00 amRNSAGM Statement
1st May 201910:01 amRNSTotal Voting Rights
10th Apr 20194:33 pmRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSEuronext Dublin Market Notice
5th Apr 201910:21 amRNSAdditional Listing
1st Apr 20194:39 pmRNSNotice of AGM
1st Apr 201910:21 amRNSTotal Voting Rights
21st Mar 20192:37 pmRNSAnnual Financial Report
20th Mar 201912:19 pmRNSHolding(s) in Company
19th Mar 201911:41 amRNSHolding(s) in Company
11th Mar 20191:05 pmRNSDirector/PDMR Shareholding - Replacement
11th Mar 201911:41 amRNSDirector/PDMR Shareholding
6th Mar 201910:57 amRNSHolding(s) in Company
4th Mar 201911:24 amRNSHolding(s) in Company
1st Mar 20198:47 amRNSTotal Voting Rights
26th Feb 20197:00 amRNSFinal Results
12th Feb 20193:59 pmRNSHolding(s) in Company
1st Feb 20199:10 amRNSTotal Voting Rights
21st Jan 20197:00 amRNSAcquisition
8th Jan 201910:45 amRNSNotice of Results
7th Jan 20194:29 pmRNSBlock listing Interim Review
3rd Jan 201912:24 pmRNSAcquisition
2nd Jan 201912:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.